首页> 外文期刊>Environmental Technology >SCALE-UP AND COST EVALUATION OF A FOAMED EMULSION BIOREACTOR
【24h】

SCALE-UP AND COST EVALUATION OF A FOAMED EMULSION BIOREACTOR

机译:泡沫乳液生物反应器的规模化升级和成本评估

获取原文
获取原文并翻译 | 示例
       

摘要

In the present paper, the potential of the foamed emulsion bioreactor (FEBR), a novel biological reactor for air pollution control was evaluated. Experimental data obtained on a laboratory-scale prototype were used to scale-up the process for a hypothetical case consisting of a contaminated air flow rate of 10,000 m~3 h~(-1), a toluene inlet concentration of 1 g m~(-3) and minimum required treatment efficiency of 92%. Reactor design and operating issues for the full-scale FEBR were identified. They included the requirement for stable foam generation with appropriate air distributors, and recycling of the auxiliary organic phase, surfactants and cells from the discharge of the reactor. The capital and operating costs for the concept full-scale FEBR were evaluated and compared to those of competing technologies, namely biofiltration, biotrickling filtration and catalytic and thermal oxidation. All three biological techniques had significantly lower capital and operating costs. Among the biological techniques, the FEBR had the lowest estimated capital cost since its greater effectiveness allowed a smaller reactor to meet the treatment objectives. The operating costs for the FEBR were higher than those of biofilters and biotrickling filters because of the requirements for nutrients and auxiliary chemicals. Overall, the results highlight that biotreatment is much more cost effective than thermal and catalytic oxidation. They further suggest that the FEBR may an interesting alternative to biofilters and biotrickling filters where the available space for air pollution control equipment is limited.
机译:在本文中,评估了泡沫乳剂生物反应器(FEBR)的潜力,这是一种用于控制空气污染的新型生物反应器。在实验室规模的原型机上获得的实验数据被用于扩大假设情况下的过程,该情况由10,000 m〜3 h〜(-1)的空气流速,1 gm〜(-的甲苯进口浓度)组成3)最低要求的治疗效率为92%。确定了全尺寸FEBR的反应堆设计和运行问题。其中包括要求使用合适的空气分配器来稳定地产生泡沫,以及从反应器的排放中回收辅助有机相,表面活性剂和泡孔。评估了概念全尺寸FEBR的资本和运营成本,并将其与竞争技术(即生物过滤,生物滴滤和催化氧化和热氧化)进行了比较。所有这三种生物技术的资本和运营成本都大大降低。在生物技术中,FEBR的估计资金成本最低,因为其更大的效力使更小的反应器可以满足治疗目标。由于对养分和辅助化学品的需求,FEBR的运营成本高于生物滤池和生物滴滤池。总体而言,结果表明,生物处理比热氧化和催化氧化更具成本效益。他们进一步认为,FEBR可能是空气过滤控制设备可用空间有限的生物滤池和生物滴滤池的有趣替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号